198 related articles for article (PubMed ID: 32134799)
1. Rabbit Fungal Keratitis Model of Fusarium solani Tested Against Three Commercially Available Antifungal Drugs.
Aung TT; Chor WHJ; Lynn MN; Chan ASY; Tan DTH; Beuerman RW
Eye Contact Lens; 2020 Sep; 46(5):274-280. PubMed ID: 32134799
[TBL] [Abstract][Full Text] [Related]
2. Antifungal efficacy of voriconazole, itraconazole and amphotericin b in experimental fusarium solani keratitis.
Yavas GF; Oztürk F; Küsbeci T; Cetinkaya Z; Ermis SS; Kiraz N; Inan UU
Graefes Arch Clin Exp Ophthalmol; 2008 Feb; 246(2):275-9. PubMed ID: 17912543
[TBL] [Abstract][Full Text] [Related]
3. Comparison of corneal collagen cross-linking (PACK-CXL) and voriconazole treatments in experimental fungal keratitis.
Özdemir HB; Kalkancı A; Bilgihan K; Göçün PU; Öğüt B; Karakurt F; Erdoğan M
Acta Ophthalmol; 2019 Feb; 97(1):e91-e96. PubMed ID: 29862655
[TBL] [Abstract][Full Text] [Related]
4. Impact of Iontophoresis and PACK-CXL Corneal Concentrations of Antifungals in an In Vivo Model.
Kalkanci A; Yesilirmak N; Ozdemir HB; Unal EA; Erdoğan M; Seker T; Tum AE; Karakus AK; Hizel K; Bilgihan K
Cornea; 2018 Nov; 37(11):1463-1467. PubMed ID: 30161054
[TBL] [Abstract][Full Text] [Related]
5. Inflammation and oxidative stress in corneal tissue in experimental keratitis due to Fusarium solani: Amelioration following topical therapy with voriconazole and epigallocatechin gallate.
Ruban VV; Archana PT; Sundararajan M; Geraldine P; Thomas PA
Mycoses; 2018 Mar; 61(3):159-171. PubMed ID: 29064157
[TBL] [Abstract][Full Text] [Related]
6. Antifungal efficacy of natamycin in experimental fusarium solani keratitis.
Dong XH; Gao WJ; He XP
Int J Ophthalmol; 2012; 5(2):143-6. PubMed ID: 22762038
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic response time of topical voriconazole 1% and intrastromal voriconazole 0.05% versus topical natamycin 5% monotherapy in Fusarium keratitis in rabbit.
Edwar L; Janna YM; Rozaliyani A; Louisa M
Mycoses; 2020 Oct; 63(10):1128-1132. PubMed ID: 32780874
[TBL] [Abstract][Full Text] [Related]
8. [Successful treatment of resistant Fusarium solani keratitis with liposomal amphotericin B].
Touvron G; Denis D; Doat M; Girard A; Brandely ML; Chast F; Renard G
J Fr Ophtalmol; 2009 Dec; 32(10):721-6. PubMed ID: 19942316
[TBL] [Abstract][Full Text] [Related]
9. Thermosensitive Tri-Block Polymer Nanoparticle-Hydrogel Composites as Payloads of Natamycin for Antifungal Therapy Against
Sha X; Chan L; Fan X; Guo P; Chen T; Liu L; Zhong J
Int J Nanomedicine; 2022; 17():1463-1478. PubMed ID: 35378880
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo antifungal activity of cetrimide (cetyltrimethyl ammonium bromide) against fungal keratitis caused by Fusarium solani.
Mahmoud YA
Mycoses; 2007 Jan; 50(1):64-70. PubMed ID: 17302751
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of topical caspofungin in experimental fusarium keratitis.
Ozturk F; Yavas GF; Kusbeci T; Cetinkaya Z; Inan UU; Ermis SS; Kiraz N
Cornea; 2007 Jul; 26(6):726-8. PubMed ID: 17592325
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Luliconazole Against Broad-Range Filamentous Fungi Including Fusarium solani Species Complex Causing Fungal Keratitis.
Todokoro D; Suzuki T; Tamura T; Makimura K; Yamaguchi H; Inagaki K; Akiyama H
Cornea; 2019 Feb; 38(2):238-242. PubMed ID: 30422866
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and Clinical Management of
Oliveira Dos Santos C; Kolwijck E; van Rooij J; Stoutenbeek R; Visser N; Cheng YY; Santana NTY; Verweij PE; Eggink CA
Front Cell Infect Microbiol; 2020; 10():133. PubMed ID: 32318355
[No Abstract] [Full Text] [Related]
14. Effect of voriconazole and ultraviolet-A combination therapy compared to voriconazole single treatment on Fusarium solani fungal keratitis.
Choi KS; Yoon SC; Rim TH; Han SJ; Kim ED; Seo KY
J Ocul Pharmacol Ther; 2014 Jun; 30(5):381-6. PubMed ID: 24724576
[TBL] [Abstract][Full Text] [Related]
15. Biofilm characterization of Fusarium solani keratitis isolate: increased resistance to antifungals and UV light.
Córdova-Alcántara IM; Venegas-Cortés DL; Martínez-Rivera MÁ; Pérez NO; Rodriguez-Tovar AV
J Microbiol; 2019 Jun; 57(6):485-497. PubMed ID: 31134579
[TBL] [Abstract][Full Text] [Related]
16. Successful medical management of recalcitrant Fusarium solani keratitis: molecular identification and susceptibility patterns.
Taylan Sekeroglu H; Erdem E; Yagmur M; Gumral R; Ersoz R; Ilkit M; Harbiyeli II
Mycopathologia; 2012 Sep; 174(3):233-7. PubMed ID: 22528742
[TBL] [Abstract][Full Text] [Related]
17.
Oliveira Dos Santos C; Kolwijck E; van der Lee HA; Tehupeiory-Kooreman MC; Al-Hatmi AMS; Matayan E; Burton MJ; Eggink CA; Verweij PE
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182529
[TBL] [Abstract][Full Text] [Related]
18. Effect of topical 0.5% povidone-iodine compared to 5% natamycin in fungal keratitis caused by Fusarium solani in a rabbit model: a pilot study.
Oliveira LA; Takata TT; Shiguematsu AI; Melo Júnior LA; Gompertz OF; Sousa LB; Mannis MJ
Arq Bras Oftalmol; 2008; 71(6):860-4. PubMed ID: 19169521
[TBL] [Abstract][Full Text] [Related]
19. Topical voriconazole as a novel treatment for fungal keratitis.
Sponsel W; Chen N; Dang D; Paris G; Graybill J; Najvar LK; Zhou L; Lam KW; Glickman R; Scribbick F
Antimicrob Agents Chemother; 2006 Jan; 50(1):262-8. PubMed ID: 16377696
[TBL] [Abstract][Full Text] [Related]
20. Antifungal Efficacy of Luliconazole in an Experimental Rabbit Model of Fungal Keratitis Caused by Fusarium solani.
Arimoto S; Inagaki K; Todokoro D; Suzuki T; Makimura K; Ishino T
Mycopathologia; 2023 Oct; 188(5):775-782. PubMed ID: 37603230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
